v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance beginning (in shares) at Dec. 31, 2024   4,952,475      
Balance beginning at Dec. 31, 2024 $ 338,365 $ 15 $ 393,186 $ (38,127) $ (16,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of stock options (in shares)   71      
Vested common stock awards (in shares)   31,012      
Stock-based compensation 2,289   2,289    
Net loss (26,441)     (26,441)  
Other comprehensive income (loss) 395       395
Ending balance (in shares) at Mar. 31, 2025   4,983,558      
Ending balance at Mar. 31, 2025 314,608 $ 15 395,475 (64,568) (16,314)
Balance beginning (in shares) at Dec. 31, 2025   5,173,884      
Balance beginning at Dec. 31, 2025 104,211 $ 15 402,378 (287,825) (10,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued for convertible notes (in shares)   231,441      
Shares issued for convertible notes 1,241   1,241    
Vested common stock awards (in shares)   19,706      
Common stock issued in lieu of fractional share (in shares)   74,276      
Stock-based compensation 1,048   1,048    
Net loss (17,650)     (17,650)  
Other comprehensive income (loss) (530)       (530)
Ending balance (in shares) at Mar. 31, 2026   5,499,307      
Ending balance at Mar. 31, 2026 $ 88,320 $ 15 $ 404,667 $ (305,475) $ (10,887)